A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

The findings highlight the need for public-health strategies aimed at mitigating dementia risk and promoting healthy aging across diverse populations, researchers said. “I think ...

But Mr Cummings said they offered evidence of how to target dementia and “this learning is going to open the door to new therapies of many types, and those drugs can be exported around the world”.

(“Alpha”) of the improved new drug ZUNVEYL（benzgalantamine delayed-release tablets）(“ZUNVEY” or the “Product”) for the treatment of mild-to-moderate dementia of the Alzheimer’s type. The Group is ...

At the end of this year, we understand different risk factors for dementia and potential treatments more deeply than ever before. Researchers working on the Lancet Commission study, part-funded by ...

By 2060, 1 million adults per year will develop dementia, according to a study published in Nature Medicine. Also in the news, chronic cannabis use may lead to chronic illness; Eli Lilly hopes to ...

Commenting on the new study, Alzheimer’s Research ... have a protective effect for the diseases that cause dementia.” “As these drugs have already been shown to be safe for use in people ...

The new Center for Genetics Guided Dementia Discovery ... and will engage in immuno-dementia drug discovery research focusing on neural inflammation and the immune system based on strong human ...